Amarin Corporation PLC Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
Biotech Bear Market: But Is It Time To Start Trading?
Article By: Rod Raynovich
Sunday, November 11, 2018 11:31 PM EST
The NASDAQ is down 1.6% and the Russell 2000 is down 1.8%, killing hopes of a continued Post-Election rally. The biotech sector is for experienced traders only. Healthcare still looks good overall with the XLV down only 0.29% at $92.95.
In this article: BMY, MRK, RHHBY, IBB, IMMU, LGND, QQQ, EXEL, NBIX, AMRN, IJR, XLV, ICPT, ABBV, SRPT, XNCR, LOXO, XLRN, IONS, REGN, CELG, GILD, VRTX, ASH, TSRO
Read
Week In Review: Sinocare Eyes $4 Billion Deal For J&J Diabetes Device Business
Article By: ChinaBio® Today
Saturday, January 20, 2018 5:34 PM EST
Sinocare, a diabetes company based in Changsha, may bid as much as $4 billion to acquire Johnson & Johnson's diabetes medical device subsidiaries. With falling revenues, some of J&J's diabetes-focused companies are exiting from the US market.
In this article: JNJ, LLY, CELG, BGNE, MRTX, AMRN
Read
Here Are 5 ‘Strong Buy’ Stocks For Under $10
Article By: TipRanks
Sunday, November 26, 2017 10:00 AM EST
Cheap stocks can be a smart choice for investors, as there are serious bargains to be found. The stocks below may be cheap, but they all have significant support from Wall Street’s best-performing analysts.
In this article: CVU, AMRN, MCRB, CDNA, MRAM
Read
E ADRs Best & Worst Report - July 11, 2016
Article By: E.B. Capital Markets
Monday, July 11, 2016 9:00 AM EST
The average ADR is trading -23.76% below its 52 week high, 2.83% above its 200 dma, has 3.72 days to cover held short, and is expected to grow its EPS by 17.58% next year.
In this article: AXS, AZN, BCE, BMO, CEO, CNQ, ECA, GSK, HMY, KEP, KT, NVO, RDY, RY, SHI, SID, SNP, STO, TU, YZC, SUBCY, GOLD, GSOL, AMRN, DRD, GLPG
Read
Tuesday Morning’s Daily Insights: PHMD, AMRN, SGYP, And BBRY
Article By: TipRanks
Tuesday, June 23, 2015 9:12 AM EST
PhotoMedex Inc. shares soared 24.5% in pre-market trading to $2.29 after the dermatological pharmaceutical company announced it will be selling two treatments to MELA Sciences in a $42.5 million cash deal.
In this article: PHMD, AMRN, SGYP, BBRY (NOW BB)
Read

PARTNER HEADLINES

Latest Tweets for $AMRN

No tweets yet!